Synonyms: MOXR 0916 | MOXR0916 | pogalizumab (deleted INN) | RG7888 | RO7021608
Compound class:
Antibody
Comment: Vonlerolizumab (MOXR0916) was an investigational humanized anti-human OX40 monoclonal, with reported preclinical efficacy [1]. Genentech terminated their Phase 2 trial NCT03029832 and have discontinued further development.
|
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
10272 | vonlerolizumab |
Synonyms |
MOXR 0916 | MOXR0916 | pogalizumab (deleted INN) | RG7888 | RO7021608 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 608 |
Other databases | |
GtoPdb PubChem SID | 315661320 |
Search PubMed clinical trials | vonlerolizumab |
Search PubMed titles | vonlerolizumab |
Search PubMed titles/abstracts | vonlerolizumab |